Spotlight Back On Indian Rotavirus Vaccine Controversy

A public interest litigation has sought to revive efforts to access segregated trial data from a locally developed oral rotavirus vaccine in India, amid concerns that it might be associated with a higher risk of intussusception in certain pockets of the country. In a further dimension, an expert panel recently brought up a "representation" on the inclusion of intussusception in the vaccine's package insert.